GlaxoSmithkline Pharmaceuticals Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2018. For the third quarter, the company’s total income was INR 8,417.7 million against INR 7,159.0 million a year ago. Profit for the period was INR 1,129.7 million against INR 896.9 million a year ago. Basic earnings per share (EPS) was INR 6.67 against INR 5.29 a year ago. For the nine months, the company’s total income was INR 24,263.3 million against INR 21,826.3 million a year ago. Profit for the period was INR 3,023.3 million against INR 2,464.3 million a year ago. Basic earnings per share (EPS) was INR 17.85 against INR 14.55 a year ago.